Black Diamond Therapeutics Inc (BDTX)
2.85
-0.28
(-8.95%)
USD |
NASDAQ |
Nov 14, 16:00
2.87
+0.02
(+0.70%)
After-Hours: 04:23
Black Diamond Therapeutics Free Cash Flow (Quarterly): -11.32M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -11.32M |
June 30, 2024 | -14.73M |
March 31, 2024 | -21.20M |
December 31, 2023 | -13.96M |
September 30, 2023 | -18.40M |
June 30, 2023 | -14.37M |
March 31, 2023 | -20.03M |
December 31, 2022 | -21.94M |
September 30, 2022 | -16.47M |
June 30, 2022 | -18.26M |
March 31, 2022 | -28.61M |
December 31, 2021 | -24.38M |
Date | Value |
---|---|
September 30, 2021 | -27.97M |
June 30, 2021 | -26.01M |
March 31, 2021 | -24.50M |
December 31, 2020 | -15.88M |
September 30, 2020 | -11.49M |
June 30, 2020 | -13.59M |
March 31, 2020 | -11.32M |
December 31, 2019 | -7.488M |
September 30, 2019 | -5.321M |
June 30, 2019 | -4.998M |
March 31, 2019 | -6.888M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-28.61M
Minimum
Mar 2022
-7.488M
Maximum
Dec 2019
-18.10M
Average
-17.36M
Median
Free Cash Flow (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 1.049B |
Vanda Pharmaceuticals Inc | -14.74M |
Ligand Pharmaceuticals Inc | 22.29M |
Agios Pharmaceuticals Inc | -84.64M |
ADMA Biologics Inc | 23.93M |